bluebird bio所有资讯

bluebird bio | 8-K：重大事件

04/17 04:12

bluebird bio | SC 13G/A：超过5%持股股东披露文件(修正)-STATE STREET CORPORATION(1.80%)

04/10 21:57

bluebird bio | 8-K：bluebird bio报告第四季度及2023年年度业绩，并重点介绍运营进展和2024年指引

03/26 19:09

bluebird bio | NT 10-K：其他

03/26 18:59

bluebird bio | 8-K：重大事件

03/18 20:05

bluebird bio | 4：持股变动声明-高管 Obenshain Andrew

03/06 06:45

bluebird bio | 4：持股变动声明-高管 Vittiglio Joseph

03/06 06:45

bluebird bio | 4：持股变动声明-高管 Colvin Richard A

03/06 06:45

bluebird bio | 4：持股变动声明-高管 Krawtschuk Christopher

03/06 06:44

bluebird bio | 4：持股变动声明-高管 Klima Thomas J

03/06 06:44

bluebird bio | SC 13G/A：超过5%持股股东披露文件(修正)-PFM Health Sciences, LP(1.9%),PFM Health Sciences GP, LLC(1.9%)等

02/15 05:14

bluebird bio | SC 13G/A：超过5%持股股东披露文件(修正)-TANG CAPITAL PARTNERS, LP(0.9%),Tang Capital Management, LLC(0.9%)等

02/15 05:05

bluebird bio | SC 13G：超过5%持股股东披露文件-Alyeska Investment Group, L.P.(6.32%),Alyeska Fund GP, LLC(6.32%)等

02/15 04:56

bluebird bio | SC 13G：超过5%持股股东披露文件-Granahan Investment Management LLC(7.38%)

02/14 22:02

bluebird bio | SC 13G/A：超过5%持股股东披露文件(修正)-The Vanguard Group(4.61%)

02/14 06:07

bluebird bio | SC 13G：超过5%持股股东披露文件-THE GOLDMAN SACHS GROUP, INC.(6.4 %),GOLDMAN SACHS & CO. LLC(6.4 %)

02/07 05:53

bluebird bio | 4：持股变动声明-高管 Klima Thomas J

02/07 05:13

bluebird bio | 4：持股变动声明-高管 Vittiglio Joseph

02/07 05:13

bluebird bio | 4：持股变动声明-高管 Obenshain Andrew

02/07 05:13

bluebird bio | SC 13G/A：超过5%持股股东披露文件(修正)-STATE STREET CORPORATION(7.28%),SSGA FUNDS MANAGEMENT, INC.(6.26%)

01/25 22:14